Development of an Application to Improve Symptoms of Sleep Apnea
We aim to commercialize a therapeutic smartphone app that analyzes apnea indices measured by our proprietary home sleep assessment device, nemurin®, using cloud-based analysis and AI to guide patients toward improvement within two weeks. nemurin?'s medical-grade measurement and analysis algorithms (patent pending) and its clinical trial framework centered on sleep clinics create high entry barriers, which are expected to improve treatment continuation rates and promote early screening for the estimated 9 million potential patients, thereby reducing medical costs. As research and development elements, the company is focusing on: ① developing a smartphone app, ② developing an AI algorithm that proposes optimized intervention plans for each patient, and ③ creating educational content to promote understanding of the condition. Ultimately, these elements will be integrated into a unified system.
